Montgomery General Hospital Selects Advanced Transfusion Management System From Global Med Technologies(R), Inc. DENVER, Jan. 10 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of an agreement for SafeTrace Tx(R)*, its advanced transfusion management with Montgomery General Hospital in Olney, Maryland. Terms were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) "We selected SafeTrace Tx for its comprehensive safety features and precise tracking of both patients and blood products," said Anne Chenoweth, Blood Bank Supervisor, of Montgomery General Hospital. Ms. Chenoweth also stated, "The implementation of SafeTrace Tx will provide us with the tools to automate and manage our processes in the transfusion service and help us provide high quality services and blood products to our patients with greater efficiency." Wm. Scott Dustin, Vice President of Sales and Marketing at Global Med Technologies, said, "We are pleased to have been selected to provide our products and services to enhance the transfusion service management of a well-established facility such as Montgomery General Hospital." Mr. Dustin added, "The delivery of accessible, quality healthcare is important to both Montgomery General Hospital and Global Med Technologies." About Montgomery General Hospital Montgomery General Hospital is a not-for-profit community hospital that serves the greater Baltimore and Washington metro areas. Services include obstetrics, surgery, physical and occupational therapy, community health education, emergency services, critical care, cancer treatment, home health care, and a 24-hour physician referral service. For more information about Rex Healthcare, visit their website at http://www.montgomerygeneral.com/. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Saharan Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: press, Wm. Scott Dustin, Vice President of Sales and Marketing, +1-916-404-8415, , or investors, Tom Marcinek, President and COO, +1-916-404-8413, , both of Wyndgate Web site: http://www.montgomerygeneral.com/ Web site: http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/

Copyright